Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Danaher Corporation    DHR

DANAHER CORPORATION

(DHR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Communiqués de presse de la société DANAHER CORPORATION
01/14CEPHEID : Receives Health Canada License for SARS-CoV-2, Flu A, Flu B and RSV Co..
AQ
01/13DANAHER CORP /DE/ : Results of Operations and Financial Condition, Financial Sta..
AQ
01/13DANAHER : CEO To Comment On Financial Performance
PR
01/07DANAHER : Schedules Fourth Quarter 2020 Earnings Conference Call
PR
01/07DANAHER : To Present At J.P. Morgan Healthcare Conference
PR
2020DANAHER : Announces Executive Appointment
PR
2020DANAHER : announces leadership appointment
PR
2020DANAHER : Pantone announces Color of the Year 2021
PU
2020DANAHER : Announces Quarterly Dividend
PR
2020DANAHER : to Present at Evercore ISI HealthCONx Conference
AQ
2020DANAHER : To Present At Evercore ISI HealthCONx Conference
PR
2020DANAHER : Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antib..
PR
2020DANAHER : to Present at Wolfe Research Healthcare Conference
AQ
2020DANAHER : To Present At Wolfe Research Healthcare Conference
PR
2020DANAHER : Releases 2020 Sustainability Report
AQ
2020DANAHER : Releases 2020 Sustainability Report
PR
2020DANAHER : Beckman Coulter launches its SARS-CoV-2 IgM antibody test in countries..
PR
2020DANAHER : Cytiva strengthens support to diagnostics industry with new labs, serv..
AQ
2020DANAHER : Reports Third Quarter 2020 Results
AQ
2020DANAHER : 3Q Earnings Snapshot
AQ
2020DANAHER : DE/ MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
2020DANAHER CORP /DE/ : Results of Operations and Financial Condition, Financial Sta..
AQ
2020DANAHER : Reports Third Quarter 2020 Results
PR
2020DANAHER : Beckman Coulter receives BARDA funding to validate Monocyte Distributi..
PR
2020DANAHER : Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives FDA Emergency Us..
PR
2020DANAHER : Schedules Third Quarter 2020 Earnings Conference Call
AQ
2020DANAHER : Schedules Third Quarter 2020 Earnings Conference Call
PR
2020DANAHER : Announces Redemption of Senior Notes
AQ
2020DANAHER CORP /DE/ : Entry into a Material Definitive Agreement (form 8-K)
AQ
2020DANAHER : Announces Redemption Of Senior Notes
PR
2020DANAHER : Announces Pricing of Senior Notes Offering
AQ
2020DANAHER : Announces Pricing Of Senior Notes Offering
PR
2020DANAHER CORPORTAION : Correction Notice To Press Release Regarding Dividend Amou..
AQ
2020CEPHEID : Receives Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B and ..
PR
2020DANAHER CORPORATION : - Correction Notice to Press Release Regarding Dividend Am..
AQ
2020DANAHER : Correction Notice To Press Release Regarding Dividend Amount
PR
2020DANAHER : Announces Quarterly Dividend
AQ
2020DANAHER : Announces Quarterly Dividend
AQ
2020DANAHER : Beckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Det..
AQ
2020DANAHER : Announces Quarterly Dividend
PR
2020DANAHER : Beckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Det..
AQ
20205 YEARS, 500 MILLION USD, AND NEARLY : Cytiva invests for global capacity expans..
AQ
2020DANAHER : Appoints Rainer M. Blair As President And CEO
PR
2020DANAHER : Beckman Coulter Launches SARS-CoV-2 IgM Antibody Test and will begin s..
PR
2020DANAHER CORP /DE/ : Results of Operations and Financial Condition, Financial Sta..
AQ
2020DANAHER : 2Q Earnings Snapshot
AQ
2020DANAHER : DE/ MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
2020DANAHER : Reports Second Quarter 2020 Results
PR
2020DANAHER : Beckman Coulter Wins SelectScience Awards for Best New Clinical Instru..
PR
2020DANAHER : Schedules Second Quarter 2020 Earnings Conference Call
AQ
2020DANAHER : Beckman Coulter Receives Nine IMV ServiceTrak™ Clinical Laborato..
PR
2020DANAHER : New Rapid Molecular Test For Tuberculosis Can Simultaneously Detect Re..
AQ
2020DANAHER : Schedules Second Quarter 2020 Earnings Conference Call
PR
2020DANAHER : Fully integrated SCIEX OS Software launches at virtual product experie..
AQ
2020DANAHER : Fully Integrated SCIEX OS Software Launches at Virtual Product Experie..
BU
2020DANAHER : Beckman Coulter, Lenco Diagnostic Laboratories deliver more than 20,00..
AQ
2020DANAHER : Beckman Coulter's SARS-CoV-2 IgG Antibody Test Receives FDA Emergency ..
PR
2020DANAHER : Beckman Coulter's SARS-CoV-2 IgG antibody test now available in market..
AQ
2020DANAHER CORP /DE/ : Entry into a Material Definitive Agreement, Termination of a..
AQ
2020CEPHEID : Announces Development of Four-in-One Combination Test for SARS-CoV-2, ..
PR
2020DANAHER : FDA Lists Beckman Coulter Life Sciences RNA Extraction Kit For Use In ..
PR
2020DANAHER : DE/ Completion of Acquisition or Disposition of Assets (form 8-K/A)
AQ
2020DANAHER : Beckman Coulter launches DxH 690T mid-volume hematology analyzer, feat..
PR
2020DANAHER : Beckman Coulter awarded expanded partnership with BARDA to assess seps..
AQ
2020DANAHER CORP /DE/ : Material Modification to Rights of Security Holders, Amendme..
AQ
2020DANAHER : Announces Closing Of Common Stock Offering And Mandatory Convertible P..
PR
2020DANAHER : Announces Pricing Of Common Stock Offering And Mandatory Convertible P..
AQ
2020DANAHER : Announces Pricing Of Common Stock Offering And Mandatory Convertible P..
PR
2020Peloton, PayPal rise; Elanco, Danaher fall
AQ
2020DANAHER : Announces Offerings Of Common Stock And Mandatory Convertible Preferre..
PR
2020DANAHER : DE/ MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
2020DANAHER : 1Q Earnings Snapshot
AQ
2020DANAHER CORP /DE/ : Results of Operations and Financial Condition, Financial Sta..
AQ
2020DANAHER CORP /DE/ : Change in Directors or Principal Officers, Submission of Mat..
AQ
2020DANAHER CORPORATION : Announces CEO Transition
PR
1  2  3  4  5  6  7Next
Upcoming event on DANAHER CORPORATION